Browsing "1. Journal Papers" by Author : 1777

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 8 of 8

This table browses all dspace content
Issue DateTitleJournal Title
2021Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor ADVANCED SCIENCE
2023Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer FRONTIERS IN ONCOLOGY
2023Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancerBRITISH JOURNAL OF CANCER
2022HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTSINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMAINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort studyGYNECOLOGIC ONCOLOGY
2022OREGOVOMAB AND NON-PLATINUM SINGLE AGENT CHEMOTHERAPY IN PARP INHIBITOR-RESISTANT OVARIAN CANCER PATIENTS NOT CANDIDATE FOR PLATINUM RETREATMENT: A MULTI-COHORT PHASE II STUDY (KGOG 3065/APGOT-OV6)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2023Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D JOURNAL FOR IMMUNOTHERAPY OF CANCER
1

Browse

Links